☆ 4.4 Article

Incidence, prevalence, hospitalization rates and treatment patterns in myasthenia gravis: A 10-year real-world data analysis of German claims data

NEUROEPIDEMIOLOGY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Clinical Neurology

Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders

Anna Rostedt Punga et al.

Summary: Autoimmune neuromuscular junction disorders are rare, with myasthenia gravis being increasingly recognized in older individuals. Various diagnostic methods, such as serological antibody, electrophysiological, imaging, and pharmacological tests, are available for these disorders. Determining if the disease is paraneoplastic is important for prognosis. However, objective biomarkers are needed to predict the disease course of myasthenia gravis and Lambert-Eaton myasthenic syndrome.

LANCET NEUROLOGY (2022)

添加到收藏夹

Article Clinical Neurology

Real-World Healthcare Resource Utilization and Cost Burden Assessment for Adults With Generalized Myasthenia Gravis in the United States

Glenn Phillips et al.

Summary: This study investigated healthcare resource utilization and associated costs for adults with generalized myasthenia gravis (gMG) in the United States. The results showed that newly diagnosed patients had higher healthcare resource utilization and costs compared to previously diagnosed patients, and costs further increased for patients with exacerbation events. For patients who experienced crisis events, costs significantly increased during the 12 months before the event and further increased in the 12 months following the event. The high costs were largely attributed to the treatments received.

FRONTIERS IN NEUROLOGY (2022)

添加到收藏夹

Article Clinical Neurology

Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT) : a multicentre, randomised, placebo-controlled, phase 3 trial

James F. Jr Jr Howard et al.

Summary: The study evaluated the safety and efficacy of efgartigimod in patients with generalised myasthenia gravis, showing that it was well tolerated and efficacious. The unique feature of individualized dosing based on clinical response in the study will provide further insights into clinical practice with longer term data from the ongoing open-label extension.

LANCET NEUROLOGY (2021)

添加到收藏夹

Editorial Material Clinical Neurology

NEUROMUSCULAR DISEASE Getting specific: targeting Fc receptors in myasthenia gravis

Jan D. Lunemann

Summary: A randomized, placebo-controlled trial found efgartigimod to be an effective therapy for generalized myasthenia gravis. If the pending FDA application is approved, it will be the first recombinant antibody-based therapy for selective IgG depletion, expanding the treatment options for myasthenia gravis.

NATURE REVIEWS NEUROLOGY (2021)

添加到收藏夹

Article Public, Environmental & Occupational Health

Myasthenia Gravis in Poland: National Healthcare Database Epidemiological Study

Ewa Sobieszczuk et al.

Summary: The study conducted in Poland for the first time looked into the epidemiology of Myasthenia gravis (MG) using data from the National Health Fund (NFZ) database. Results showed that as of January 1, 2019, there were 8,702 MG patients receiving symptomatic treatment, with a female to male ratio of 1.65:1. The incidence of MG was 2.36 per 100,000, with different age groups showing variations in prevalence and onset of the disease. This information can be valuable for evaluating healthcare resources needed for MG patients.

NEUROEPIDEMIOLOGY (2021)

添加到收藏夹

Article Behavioral Sciences

Epidemiology of Myasthenia Gravis in Sweden 2006-2016

Elisabet Westerberg et al.

BRAIN AND BEHAVIOR (2020)

添加到收藏夹

Letter Oncology

The impact of the temporary suspension of national cancer screening programmes due to the COVID-19 epidemic on the diagnosis of breast and colorectal cancer in the Netherlands

Avinash G. Dinmohamed et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)

添加到收藏夹

Article Medicine, General & Internal

Myasthenia gravis

Nils Erik Gilhus et al.

NATURE REVIEWS DISEASE PRIMERS (2019)

添加到收藏夹

Article Clinical Neurology

Hospital admission and prevalence trends of adult myasthenia gravis in Finland in 2004-2014: A retrospective national registry study

Jussi O. T. Sipila et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2019)

添加到收藏夹

Article Clinical Neurology

A nationwide epidemiological study of myasthenia gravis in Latvia

A. Zieda et al.

EUROPEAN JOURNAL OF NEUROLOGY (2018)

添加到收藏夹

Article Clinical Neurology

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard et al.

LANCET NEUROLOGY (2017)

添加到收藏夹

Article Health Care Sciences & Services

Status and perspectives of claims data analyses in Germany-A systematic review

Kristine Kreis et al.

HEALTH POLICY (2016)

添加到收藏夹

Review Clinical Neurology

Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society

Nico Melzer et al.

JOURNAL OF NEUROLOGY (2016)

添加到收藏夹

Review Clinical Neurology

International consensus guidance for management of myasthenia gravis: Executive summary

Donald B. Sanders et al.

NEUROLOGY (2016)

添加到收藏夹

Article Medicine, General & Internal

Randomized Trial of Thymectomy in Myasthenia Gravis

G. I. Wolfe et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

添加到收藏夹

Review Clinical Neurology

Myasthenia gravis: subgroup classification and therapeutic strategies

Nils Erik Gilhus et al.

LANCET NEUROLOGY (2015)

添加到收藏夹

Review Clinical Neurology

A systematic review of population based epidemiological studies in Myasthenia Gravis

Aisling S. Carr et al.

BMC NEUROLOGY (2010)

添加到收藏夹

Article Health Care Sciences & Services

Quality of life and life circumstances in German myasthenia gravis patients

Sabine Twork et al.

HEALTH AND QUALITY OF LIFE OUTCOMES (2010)

添加到收藏夹

Review Public, Environmental & Occupational Health

The Incidence of Myasthenia Gravis: A Systematic Literature Review

Anita McGrogan et al.

NEUROEPIDEMIOLOGY (2010)

添加到收藏夹

Review Public, Environmental & Occupational Health

Review on use of German health insurance medication claims data for epidemiological research

Falk Hoffmann

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2009)

添加到收藏夹

Review Clinical Neurology

Lifetime course of myasthenia gravis

David Grob et al.

MUSCLE & NERVE (2008)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.